Paczosa, Michelle K; Fisher, Michael L; Maldonado-Arocho, Francisco J et al. (2014) Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection. Cell Microbiol 16:247-68
|
Maldonado-Arocho, Francisco J; Green, Carlos; Fisher, Michael L et al. (2013) Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog 9:e1003415
|
Rolán, Hortensia G; Durand, Enrique A; Mecsas, Joan (2013) Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection. Cell Host Microbe 14:306-17
|
Durand, Enrique A; Maldonado-Arocho, Francisco J; Castillo, Cynthia et al. (2010) The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell Microbiol 12:1064-82
|
Songsungthong, Warangkhana; Higgins, Mary C; Rolán, Hortensia G et al. (2010) ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice. Cell Microbiol 12:988-1001
|
Davis, Alison J; Díaz, Dennise A De Jesús; Mecsas, Joan (2010) A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia. Mol Microbiol 76:236-59
|
Garrity-Ryan, Lynne K; Kim, Oak K; Balada-Llasat, Joan-Miquel et al. (2010) Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun 78:4683-90
|
McCoy, Melissa W; Marré, Meghan L; Lesser, Cammie F et al. (2010) The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect Immun 78:2584-98
|
Ren, Zhihong; Gay, Raina; Thomas, Adam et al. (2009) Effect of age on susceptibility to Salmonella Typhimurium infection in C57BL/6 mice. J Med Microbiol 58:1559-67
|
Balada-Llasat, Joan-Miquel; Panilaitis, Bruce; Kaplan, David et al. (2007) Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Vaccine 25:1526-33
|
Showing the most recent 10 out of 15 publications